Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2025 ∙ Fletcher, M. A. Okasha, O. Baay, M. Syrochkina, M. Hayford, K.

Complicated pneumococcal pneumonia in the era of higher-valent pneumococcal conjugate vaccines: a systematic literature review and meta-analysis, 2001-2022

  • All age groups
  • Pneumococcal disease
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Wang, Z. Zhang, H. Zhu, Y. Jiang, Y. Yang, D. Zou, X. Fang, Y.

Comprehensive evaluation of prophylactic HPV vaccines: a systematic review and meta-analysis of efficacy, safety, and immunogenicity in males and females

  • All age groups
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Wang, W. Sawleshwarkar, S. Piraveenan, M.

Computational approaches of modelling human papillomavirus transmission and prevention strategies: a systematic review

  • All age groups
  • Human papillomavirus (HPV)
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Samal, J. Preetha, G. S. Kumar, R. P. Lakshman, N. Dehury, R. K. Singh, H.

Coronavirus Disease 2019 Vaccine Hesitancy and Acceptance among the Indian Population: A Systematic Review and Meta-Analysis

  • South-East Asia
  • India
  • Adolescents
  • Adults
  • Older adults
  • Healthcare workers
  • Parents/caregivers
  • Pregnant women
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Felsher, M. Fisher-Borne, M. Malik, T. Santpurkar, N. Martin, S. Zaidi, O. Wang, W. Palmer, C.

Cost-effectiveness modeling for gender-neutral human papillomavirus vaccines: A systematic literature review

  • Children
  • Adolescents
  • Adults
  • Older adults
  • Human papillomavirus (HPV)
  • Economic aspects
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Fu, X. Xia, Y. Zhou, W. Lu, Y.

Cost-effectiveness of human papillomavirus vaccination among girls aged 9-16 years in China: a meta-analysis

  • Western Pacific
  • China
  • Adolescents
  • Human papillomavirus (HPV)
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Tamir, T. T. Tekeba, B. Techane, M. A. Alemu, T. G. Wubneh, C. A. Wassie, Y. A.

Coverage of complete basic childhood vaccination and its variation by basic characteristics among children aged 12-23 months in 41 low- and middle-income countries: A Meta-analysis of demographic and health survey reports between 2015 and 2025

  • Newborn
  • Children
  • Low and Middle Income Countries
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Cheuyem, F. Z. L. Amani, A. Achangwa, C. Ajong, B. N. Minkandi, C. A. Zeh, M. M. M. K. Ntsek, L. L. E. Essomba, J. P. Jiogue, R. C. Ndagijimana, O. Nchanji, N. E. Danwang, C.

COVID- 19 vaccine uptake and its determinants in Cameroon: a systematic review and meta-analysis (2021-2024)

  • Africa
  • Cameroon
  • All age groups
  • Healthcare workers
  • COVID-19
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Karimi, R. Norozirad, M. Esmaeili, F. Mansourian, M. Marateb, H. R.

COVID-19 Vaccination and Cardiovascular Events: A Systematic Review and Bayesian Multivariate Meta-Analysis of Preventive Benefits and Risks

  • All age groups
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ McCosker, L. K. Dyer, B. Sudarmana, T. Seale, H. Ware, R. S.

COVID-19 vaccination uptake in people experiencing homelessness during the first three years of the global COVID-19 vaccination effort: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Coverage
  • Administration
Methodological quality (AMSTAR 2):
Not applicable
Loading...